SMARTPHLEX
LIVE

Serial Number

79250945

Owner

PharmaLex GmbH

Attorney

Mark J. Liss

Filing Date

Jul 2, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SMARTPHLEX Trademark

Serial Number: 79250945 • Registration: 6060922

SMARTPHLEX is a trademark filed by PharmaLex GmbH on July 2, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PharmaLex GmbH (10 trademarks)

Bahnstrasse 42-46

Entity Type: 99

Trademark Details

Filing Date

July 2, 2018

Registration Date

May 26, 2020

Published for Opposition

March 10, 2020

Goods & Services

Assistance and consultancy in the context of medicine production, namely, manufacturing process consulting

Software for supporting product development processes and regulatory compliance; software for automation of routine processes and report generation; artificial intelligence software for supporting decision making processes; computer programs for data processing; downloadable computer software applications for supporting product development processes and regulatory compliance; unified communications software for supporting decision making processes; assistive software for supporting product development processes and regulatory compliance; all the foregoing in the fields of medical devices, consumer healthcare, animal healthcare, pharmaceuticals and biopharmaceuticals

Advertising services, business management for others, company administration in the nature of business administration services; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy services in the field of retailing services and wholesaling services related to medicines; provision of outsourcing services in the field of business management for companies engaged in the field of medicine development, authorization, production, sale, safety and monitoring; assistance and consultancy in the field of business management of companies engaged in medicine and medical device authorization and lifecycle maintenance, namely, automation of content compilation and document dossier development, automation for creation of documents for achieving medical marketing authorization and marketing approval; regulatory submission management, namely, assisting others in filing of documents with regulatory authorities for authorizing and lifecycle maintenance of medicines and medical devices using documents, reports and files required by regulatory authorities via automation of content compilation and document dossier development, automation for creation of documents for achieving medical marketing authorization and marketing approval

Medical and veterinary medical services; pharmacy advice in the nature of pharmaceutical advice; providing information relating to medicine; providing information relating to the preparation and dispensing of medications; advisory services relating to pharmaceuticals, namely, pharmaceutical advice

Scientific and technological services and research and design relating thereto, namely, scientific research and laboratory research in the field of pharmaceuticals; industrial analysis and research services, namely, laboratory research services relating to pharmaceuticals and pharmaceutical research services; research and development of new products for others in the field of pharmaceuticals; provision of scientific surveys in the field of pharmaceuticals in the nature of scientific research; development of a web application for inputting and using informative texts for medicines and medical products, in particular user guides, packaging inserts, specialist information, and for providing various documents; database services, namely, electronic storage of data in computer databases; conversion of data or documents from physical to electronic media; scientific research; scientific research and analysis in the field of pharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology consultancy services provided to the pharmaceutical and healthcare industries; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticals, namely, pharmaceutical product evaluation; new product design services, namely, analysis and evaluation of product design; product development consultation, namely, analysis and evaluation of new product development; quality control testing for others, namely, product testing; materials testing and evaluation; product safety testing; quality control services, namely, testing, analysis and evaluation of the services of others to determine conformity with certification standards; quality testing of products for others to determine conformity with certification standards; development, updating and maintenance of software and database systems; development of software for data and multimedia content conversion from and to different protocols; Providing temporary use of on-line, non-downloadable software for publishing and printing written materials for improving gains in efficiency with client operations; providing temporary use of on-line non-downloadable software for the management of information; providing temporary use of on-line non-downloadable software for the transmission of information; providing temporary use of on-line non-downloadable software for the transmission of data; providing temporary use of on-line non-downloadable software for the management of data; software as a service (SAAS) services featuring software for the management and transmission of information and data; rental of software for data processing; all the foregoing in the fields of medical devices, consumer healthcare, animal healthcare, pharmaceuticals and biopharmaceuticals

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 26, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 18, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 24, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 24, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 26, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
May 26, 2020 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
May 21, 2020 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Mar 6, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 19, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 19, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 31, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 31, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 31, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 31, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 28, 2020 GNFN
FINAL REFUSAL E-MAILED
Jan 28, 2020 GNFR
FINAL REFUSAL WRITTEN
Jan 28, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 4, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 4, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 4, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2019 CRFA
ASSIGNED TO LIE
Aug 5, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 16, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 21, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 13, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 12, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 12, 2019 MAFR
ASSIGNED TO EXAMINER
Feb 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 31, 2019 REPR